Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341159 · ClinicalTrials.gov registry record
Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 9,257
- Enrollment target
NCT00341159: Completed study, sponsored by National Human Genome Research Institute (NHGRI).
NCT00341159 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 9,257 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00341159 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 9,257 participants
- Enrollment target
Study Summary
This study will continue to analyze data collected by the Women's Contraceptive and Reproductive Experiences (CARE) study. The CARE study was designed to evaluate the association between reproductive factors and risk of breast cancer in white and African-American women in the United States. The present study is not recruiting additional participants. The original study enrolled 4,575 women with breast cancer and 4,682 control subjects between 35 and 64 years of age All participants provided a blood sample for genetic study. The samples were analyzed for variants (mutations) in the BRCA1 and BRCA2 genes, the vitamin D receptor gene, the androgen receptor gene, and the insulin-like growth factor-1 gene. In addition, all participants were interviewed to obtain information related to breast cancer risk, including a history of reproductive, menstrual, oral contraceptive, and hormone replacement therapy use; lifestyle factors such as smoking, alcohol use, body weight, and physical activity; history of medical conditions and procedures; demographic characteristics, such as age, race, marital status, and so forth; and a detailed family history of cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,257 participants |
| Start Date | 2005-01-18 |
| Est. Completion | 2015-02-24 |
What the finished NCT00341159 record still lists
NCT00341159 is an observational study that tracks outcomes without assigning an intervention. Its 9,257 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00341159 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00341159 about?
NCT00341159 is a clinical study titled "Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study". This study will continue to analyze data collected by the Women's Contraceptive and Reproductive Experiences (CARE) study. The CARE study was designed to evaluate the association between reproductive factors and risk of breast cancer in white and African-American women in the United States. The pre...
What is the current status of trial NCT00341159?
This trial is currently completed. The enrollment target is 9,257 participants. The study started on 2005-01-18. Estimated completion is 2015-02-24.
Who is sponsoring clinical trial NCT00341159?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
- NCT05080673 · 9,500 participants · NA
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI